Found 97 matching trials
A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) PHASE3 This is a Phase III, multicenter, randomized, placebo-controlled trial desi...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoadjuvant Treatment of Breast Cancer N/A Observational investigation of participants who are given neoadjuvant treat...
Show More Location
National Institute of Oncolgy
Learn More & Join Trial
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency PHASE3 The purpose of this trial is to compare the 3-year disease-free survival of...
Show More Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Efficacy and Safety of Neoadjuvant DC-T in Breast Cancer Patients PHASE4 This is a multicentric, open-label,non-randomized concurrent control, 1:1 m...
Show More Learn More & Join Trial
Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer PHASE2 The purpose of this trial is to evaluate efficacy and toxicity of either th...
Show More Status
Active Not Recruiting
Location
Dept. of Oncology, Örebro University Hospital
Learn More & Join Trial
Neoadjuvant Chemotherapy + Herceptin in HER2 Positive Stage II-III Breast Cancer Patients PHASE2 The purpose of this study is to evaluate the effectiveness and tolerability...
Show More Location
Advanced Medical Specialties
Learn More & Join Trial
A Study of Pertuzumab in Combination With Herceptin and Chemotherapy in Participants With HER2-Positive Breast Cancer PHASE2 This 3 arm study will assess the tolerability, safety and efficacy of 3 neo...
Show More Location
Multiple Locations
Learn More & Join Trial
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE Trial PHASE2 VALENTINE is a parallel, non-comparative, three-arm, randomized 1:2:2 open-...
Show More Status
Active Not Recruiting
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy PHASE2 The purpose of this study is to establish a prospective, single-center plat...
Show More Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Learn More & Join Trial